Morales T I
Bone Research Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland 20892.
Arch Biochem Biophys. 1994 Nov 15;315(1):190-8. doi: 10.1006/abbi.1994.1489.
Previous studies showed that retinoic acid is a powerful resorbing agent for articular cartilage at physiological doses (10(-8) to 10(-10) M); the possible role of individual cytokines in the reversal of this effect is now explored in bovine articular cartilage organ cultures. Seven days of treatment with the retinoid under serum-free conditions, at 1 x 10(-8) M, led to a suppression of proteoglycan synthesis of 90 +/- 5% (n = 6; n = cultures from different animals; mean +/- SD) and to a net loss of 64 +/- 14% (n = 6). Removal of the retinoid from the feeding medium did not significantly increase proteoglycan synthesis nor diminish the further loss of proteoglycans. Thus, transforming growth factor-beta (TGF-beta) and insulin-like growth factor-1 (IGF-1), cytokines which independently maintain proteoglycan homeostasis (Morales and Roberts, 1988, J. Biol. Chem. 263, 828; and Luyten et al., 1988, Arch. Biochem. Biophys. 267, 416), were tested. TGF-beta (10 ng/ml) or IGF-1 (10 ng/ml) added for 7 days to serum-free medium following retinoic acid treatment led to recoveries of proteoglycan synthesis of 74 +/- 24% (n = 12) and 69 +/- 18% (n = 12), respectively, as compared to controls switched from serum-free conditions to corresponding cytokine treatments. TGF-beta + IGF-1 restored activity to 95 +/- 17% (n = 12) of controls. TGF-beta s 1-3 exhibited identical responses in control and experimental cultures. IGF-2 replaced IGF-1, but a fourfold higher concentration was required; insulin also had IGF-1-like effects, but even at 500 ng/ml it was 25% less effective than IGF-1. In contrast to the cultures switched from retinoic acid treatment to serum-free conditions, the cultures switched to IGF-1, TGF-beta, or IGF-1 + TGF-beta were stabilized from further proteoglycan loss by the treatment; after 1 week, tissue levels were 97 +/- 19, 96 +/- 22, and 114 +/- 15% (n = 6), respectively, compared to the content before switching. Measurements of catabolism were in agreement with these observations. It is proposed that retinoic acid, TGF-beta, and IGF-1 are parts of an endogenous system involved in the reversible modulation of proteoglycan homeostasis in articular cartilage.(ABSTRACT TRUNCATED AT 400 WORDS)
先前的研究表明,视黄酸在生理剂量(10⁻⁸至10⁻¹⁰M)下是一种强有力的关节软骨吸收剂;目前在牛关节软骨器官培养物中探索了个别细胞因子在逆转这种作用方面的可能作用。在无血清条件下,用1×10⁻⁸M的类视黄醇处理7天,导致蛋白聚糖合成抑制90±5%(n = 6;n为来自不同动物的培养物;平均值±标准差),净损失64±14%(n = 6)。从培养基中去除类视黄醇并没有显著增加蛋白聚糖合成,也没有减少蛋白聚糖的进一步损失。因此,测试了转化生长因子-β(TGF-β)和胰岛素样生长因子-1(IGF-1),这两种细胞因子可独立维持蛋白聚糖稳态(莫拉莱斯和罗伯茨,1988年,《生物化学杂志》263卷,828页;以及吕滕等人,1988年,《生物化学与生物物理学报》267卷,416页)。视黄酸处理后,在无血清培养基中添加TGF-β(10 ng/ml)或IGF-1(10 ng/ml)7天,与从无血清条件转换为相应细胞因子处理的对照组相比,蛋白聚糖合成的恢复分别为74±24%(n = 12)和69±18%(n = 12)。TGF-β + IGF-1使活性恢复到对照组的95±17%(n = 12)。TGF-β 1-3在对照和实验培养物中表现出相同的反应。IGF-2替代了IGF-1,但需要四倍高的浓度;胰岛素也有类似IGF-1的作用,但即使在500 ng/ml时,其效果也比IGF-1低25%。与从视黄酸处理转换为无血清条件的培养物不同,转换为IGF-1、TGF-β或IGF-1 + TGF-β的培养物通过该处理稳定下来,不再进一步损失蛋白聚糖;1周后,与转换前的含量相比,组织水平分别为97±19%、96±22%和114±15%(n = 6)。分解代谢的测量结果与这些观察结果一致。有人提出,视黄酸、TGF-β和IGF-1是参与关节软骨中蛋白聚糖稳态可逆调节的内源性系统的组成部分。(摘要截取自400字)